Stock Price Quote

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2023.3030.7 (+1.54 %)
PREV CLOSE ( ) 1992.60
OPEN PRICE ( ) 2012.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 93
TODAY'S LOW / HIGH ( )1991.30 2030.00
52 WK LOW / HIGH ( )1161.35 2425.1
NSE2023.1521.9 (+1.09 %)
PREV CLOSE( ) 2001.25
OPEN PRICE ( ) 2007.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2758
TODAY'S LOW / HIGH( ) 1992.75 2060.00
52 WK LOW / HIGH ( )1175.05 2439.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1981
Management Info
- Chairman Rahul J Nachane - Managing Director
Registered Office

Address 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone 022 26636450

Email info@nglfinechem.com

Website www.nglfinechem.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE

NEWS

18Sep NGL Fine-Chem informs about disclosure
NGL Fine-Chem has informed that it enclosedthe disclosure under Regulati..
13Sep NGL Fine-Chem informs about disclosure
NGL Fine-Chem has informed that the exchange has received the disclosure..
11Sep NGL Fine-Chem informs about disclosure
NGL Fine-Chem has informed that the Exchange has received the disclosure..
08Sep NGL Fine-Chem informs about disclosure
NGL Fine-Chem has informed that the exchange has received the disclosure..
28Jul NGL Fine-Chem informs about details of
NGL Fine-Chem has informed about loss of Share Certificate. Name of the..

Financials

in Millions
QTR Jun 23 ANNUAL 23
Net Profit78.0599999999999201.19
Gross Profit 91.6099999999999 266
Operating Profit 114.03356.96
Net Sales 691.132750.52

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Guj. Themis Biosyn (BSE)
peergroup  932.00 (5.36%)
M.Cap ( in Cr)1354.08
Dr. Reddy's Lab (BSE)
peergroup  5468.10 (0.53%)
M.Cap ( in Cr)91199.58
Pfizer (BSE)
peergroup  3863.15 (0.71%)
M.Cap ( in Cr)17673.04
Divi's Lab (BSE)
peergroup  3752.95 (0.61%)
M.Cap ( in Cr)99629.03
RPG Life Sciences (BSE)
peergroup  1317.75 (1.73%)
M.Cap ( in Cr)2179.43

Shareholding Pattern

PROMOTERS 73.53%
NON-INSTITUTION 26.46%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About NGL Fine-Chem Ltd.

NGL Fine-Chem Ltd. was incorporated in the year 1981. Its today's share price is 2023.3. Its current market capitalisation stands at Rs 1250 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2750.53 Cr and Total Income of Rs.2826.65 Cr. The company's management includes Pallavi Pednekar, Rajesh N Lawande, Rahul J Nachane, Sarala Menon, Milind V Shinde, Jayaram Sitaram, Ajita Nachane.

It is listed on the BSE with a BSE Code of 524774 , NSE with an NSE Symbol of NGLFINE and ISIN of INE887E01022. It's Registered office is at 301 E Square,Subhash Road,Vile Parle (East)Mumbai-400057, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bharat Gandhi & Co, Manek & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.